Teva Pharmaceutical Industries Limited
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2014 | — | — | $2.23B |
| Dec 2015 | — | — | $6.95B |
| Jan 2016 | — | — | $6.95B |
| Dec 2016 | $58.06B | $93.06B | $988.0M |
| Mar 2017 | — | — | $900.0M |
| Jun 2017 | — | — | $599.0M |
| Sep 2017 | — | — | $680.0M |
| Dec 2017 | $51.87B | $70.62B | $963.0M |
| Mar 2018 | $49.08B | $69.18B | $1.42B |
| Jun 2018 | $47.66B | $67.03B | $1.86B |
| Sep 2018 | $45.93B | $65.06B | $1.88B |
| Dec 2018 | $44.89B | $60.68B | $1.78B |
| Mar 2019 | $44.03B | $59.85B | $1.97B |
| Jun 2019 | $44.17B | $59.42B | $2.17B |
| Sep 2019 | $42.32B | $57.25B | $1.24B |
| Dec 2019 | $42.41B | $57.47B | $1.98B |
| Mar 2020 | $40.74B | $55.33B | $1.80B |
| Jun 2020 | $40.17B | $54.99B | $2.40B |
| Sep 2020 | $39.15B | $49.74B | $1.83B |
| Dec 2020 | $39.58B | $50.64B | $2.18B |
| Mar 2021 | $38.03B | $49.00B | $1.74B |
| Jun 2021 | $37.88B | $49.20B | $2.44B |
| Sep 2021 | $36.40B | $47.85B | $2.05B |
| Dec 2021 | $36.42B | $47.67B | $2.17B |
| Mar 2022 | $36.80B | $47.06B | $2.18B |
| Jun 2022 | $36.12B | $45.93B | $2.06B |
| Sep 2022 | $34.75B | $44.25B | $2.23B |
| Dec 2022 | $35.41B | $44.01B | $2.80B |
| Mar 2023 | $34.96B | $43.46B | $2.14B |
| Jun 2023 | $35.51B | $43.10B | $2.67B |
| Sep 2023 | $34.71B | $42.10B | $2.25B |
| Dec 2023 | $35.35B | $43.48B | $3.23B |
| Mar 2024 | $35.23B | $42.77B | $2.99B |
| Jun 2024 | $34.77B | $41.34B | $2.26B |
| Sep 2024 | $35.38B | $41.76B | $3.32B |
| Dec 2024 | $33.61B | $39.33B | $3.30B |
| Mar 2025 | $32.15B | $38.42B | $1.70B |
| Jun 2025 | $33.30B | $40.13B | $2.16B |
| Sep 2025 | $32.60B | $39.86B | $2.20B |
| Dec 2025 | $32.83B | $40.75B | $3.56B |
| Mar 2026 | $31.81B | $40.04B | $3.74B |
| Jun 2026 | $32.10B | $39.86B | $3.66B |